Related Experiment Video
Updated: Jan 31, 2026
In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Gout and cardiovascular disease: crystallized confusion
Aryeh M Abeles1, Michael H Pillinger2
1Division of Rheumatology, University of Connecticut Health Center, Meriden.
Insights
Treating gout may reduce cardiovascular risk, but evidence remains conflicting. Further research is needed to confirm benefits of urate-lowering therapy and explore other gout medications for cardiovascular outcomes.
Area of Science:
- Rheumatology
- Cardiology
- Internal Medicine
Background:
- Gout is linked to increased cardiovascular morbidity and mortality.
- The exact biological relationship between gout and cardiovascular disease is uncertain.
- Establishing a causal link requires demonstrating reduced cardiovascular risk with gout treatment.
Purpose of the Study:
- To review recent studies on the relationship between gout and cardiovascular disease.
- To assess whether treating gout impacts cardiovascular risk.
- To explore potential benefits of different gout treatment strategies on cardiovascular outcomes.
Main Methods:
- Review of recent scientific literature addressing gout and cardiovascular disease.
- Analysis of studies investigating the impact of lowering serum uric acid levels.
- Examination of research on various gout treatment strategies and their cardiovascular effects.
Main Results:
- Conflicting study results exist regarding the cardiovascular benefits of lowering serum uric acid.
- Inconsistencies in study design may explain varied outcomes.
- The cardiovascular impact of different gout treatment strategies remains unclear.
Conclusions:
- It is currently unclear if urate-lowering therapy for gout offers cardiovascular benefits.
- Further studies are required to determine if specific urate-lowering drugs have differential cardiovascular risks or benefits.
- Non-urate-lowering agents like colchicine and statins may also influence cardiovascular outcomes in gout patients.
Purpose Of Review:
Gout is associated with the risk of cardiovascular morbidity and mortality, but the biological relationship between the two remains uncertain. The demonstration of reduction of cardiovascular risk with appropriate gout treatment would argue for a causal role for gout in cardiovascular disease. We reviewed recent studies that address the relationship between gout and cardiovascular disease.
Recent Findings:
Studies are conflicting; some show that lowering serum uric acid levels leads to better cardiovascular outcomes, whereas others show no such benefit. Inconsistencies in study design may contribute to these variations in outcome. Additionally, different gout treatment strategies may affect cardiovascular outcomes differently.
Summary:
Despite an abundance of data generated in the last 5 years, it remains unclear whether treating gout with urate-lowering therapy provides a cardiovascular benefit. Additionally, further studies are needed to clarify whether different urate-lowering drugs confer different cardiovascular risks or benefits. Nonurate-lowering agents used for gout or commonly used in gout patients, such as colchicine and statins, may also improve cardiovascular outcomes in this population.
More Related Videos
Related Concept Videos
01:27Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
02:42Ionic Crystal Structures
Most monatomic ions behave as charged spheres, and their attraction for ions of opposite charge is the same in every direction. Consequently, stable structures for ionic compounds result (1) when ions of one charge are surrounded by as many ions as possible of the opposite...
01:25Crystal Growth: Principles of Crystallization
Initiating crystallization involves manipulating the concentration of the solute and the temperature of the solution. Since crystal growth occurs when the ratio of concentration and solubility of the solute in the solvent...
01:14Overview of the Cardiovascular System
Heart
The heart is the central pump of the cardiovascular system that circulates blood throughout the body. It comprises two atria receiving the blood and two ventricles pumping blood out of the heart. Their rhythmic contractions, called heartbeats, ensure that blood flow remains continuous.
Blood Vessels
Blood...
02:58Crystal Field Theory - Octahedral Complexes
To explain the observed behavior of transition metal complexes (such as colors), a model involving electrostatic interactions between the electrons from the ligands and the electrons in the unhybridized d orbitals of the central metal atom has been developed. This electrostatic model is crystal field theory (CFT). It helps to understand, interpret, and predict the colors, magnetic behavior, and some structures of coordination compounds of transition metals.
CFT focuses on...
01:27Regulation of the Cardiovascular System
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...